Umashanker Navik
About
In The Last Decade
Umashanker Navik
47 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 796
- Cardiology and Cardiovascular Medicine 355
- Oncology 197
- Physiology 192
- Endocrinology, Diabetes and Metabolism 191
Countries citing papers authored by Umashanker Navik
This map shows the geographic impact of Umashanker Navik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umashanker Navik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umashanker Navik more than expected).
Fields of papers citing papers by Umashanker Navik
This network shows the impact of papers produced by Umashanker Navik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umashanker Navik. The network helps show where Umashanker Navik may publish in the future.
Co-authorship network of co-authors of Umashanker Navik
This figure shows the co-authorship network connecting the top 25 collaborators of Umashanker Navik. A scholar is included among the top collaborators of Umashanker Navik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umashanker Navik. Umashanker Navik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 11 | |
| 4 | 13 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | 36 | |
| 9 | 15 | |
| 10 | 15 | |
| 11 | 10 | |
| 12 | 12 | |
| 13 | Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives breakdown → | 387 |
| 14 | Gene therapy: Comprehensive overview and therapeutic applications breakdown → | 186 |
| 15 | 13 | |
| 16 | Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management breakdown → | 584 |
| 17 | 12 | |
| 18 | 29 | |
| 19 | 18 | |
| 20 | 31 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.